期刊文献+

C反应蛋白对3T3-L1脂肪细胞内高分子量多聚体脂联素表达和脂联素多聚化水平的影响 被引量:4

Effects of C-reactive protein on the expression of high-molecular-weight adiponectin and assembly of adiponectin
下载PDF
导出
摘要 目的 C反应蛋白(C-reactive protein,CRP)作为炎症因子在糖尿病等代谢相关疾病早期即显著升高,而脂联素具有抗炎、抗糖尿病、抗动脉粥样硬化,在糖尿病疾病中表达水平下降。探讨CRP对3T_3-L1脂肪细胞内高分子量多聚体脂联素(high molecular weight adiponectin,HMWA)和脂联素多聚化水平的影响。方法选用3T_3-L1脂肪前体细胞株,诱导分化成熟后,50μg/m L CRP刺激0、6、12、24 h后或0、5、25、50μg/m L刺激24 h分别收集蛋白,通过Western blot方法检测HMWA表达。0、50μg/m L刺激24 h后,实时定量PCR检测脂联素多聚化相关调控基因(Ero1-L、Dsb A-L、ERp44)水平。结果与0μg/m L的CRP对HMWA的表达量(1.00±0.00)比较,5μg/m L的表达量(0.88±0.17)有所下降(P>0.05),而25、50μg/m L的相对表达量(0.70±0.07、0.44±0.07)明显下降(P<0.05)。与CRP诱导0 h脂联素表达(1.00±0.00)比较,诱导6 h的表达(0.84±0.07)差异无统计学意义(P>0.05),而诱导12、24 h后,脂联素表达(0.71±0.06、0.48±0.11)明显下降(P<0.05)。与CRP 0μg/m L相比,CRP 50μg/m L刺激24 h后,Ero1-L基因、Dsb A-L表达降低,而ERp44显著升高(P<0.05)。结论 CRP通过减少HMWA的表达以及抑制脂联素多聚化以减弱脂联素在疾病中所起的积极作用,从而部分参与了CRP加速炎症相关代谢疾病的发生发展。 Objective C reactive protein( CRP),an inflammatory maker, increased significantly among diabetes mellitus and other metabolic diseases. Meanwhile,adiponectin plays a vital role in anti-atherogenic,anti-inflammatory and anti-diabetic potentials. Further,it decreased in diabetes mellitus. To investigate the effects of C-reactive protein in the expression of high-molecular-weight adiponectin( HMWA) and adiponectin multimerization. Methods The fully differentiated 3T_3-L1 cells were respectively treated with 50μg /m L CRP for 0 h、6 h、12 h and 24 h,and different doses of CRP with 0 μg / m L、5 μg / m L、25 μg / m L、50 μg / m L for 24 h. The expression of HMWA was further detected by Western blot. Additionally,the mRNA expressions of adiponectin assembly related genes( Ero1-L、Dsb A-L、ERp44) were detected by Real time PCR after 50μg /m L CRP treatment for 24 h. Results After 24 h treatment,25 μg /m L CRP and 50μg /m L CRP resulted in a substantial reduction( [70 ± 7]% vs [44 ± 7]%,P 0. 05) while 5 μg/m L CRP revealed no change. With the dose of 50 μg/m L CRP treated,the expression of HWMA were both inhibited after the 12 h and 24 h CRP treatment( [71 ± 6]% vs [48 ± 11]%,P 0. 05),but for the 6h CRP treatment group,HWMA remained unchanged. Additionally,CRP inhibited Ero1-L( 86 ± 10) % and Dsb A-L( 72 ± 6) % gene expression and upregulated the expression of ERp44( 141 ± 23) %. Conclusion CRP decreases HMWA expression in a dose and time-dependent manner and inhibits the multimerization of adiponectin,thus weaken the benefits of adiponectin in diabetes.
出处 《医学研究生学报》 CAS 北大核心 2016年第3期230-234,共5页 Journal of Medical Postgraduates
基金 国家自然科学基金(81570721,81370965) 江苏省自然科学基金(BK20151331,BK2009208) 江苏省“六大人才高峰”第十二批次高层次人才项目(2015-WSN-006) 江苏省卫生厅国际交流支撑计划及面上科技项目(H201247) 镇江市科技支撑-社会发展项目(SH2015042,SH2012027,SH2013035)
关键词 C反应蛋白 脂联素 高分子多聚体脂联素 3T3-L1细胞 C-reactive protein Adiponectin High-molecular-weight adiponectin Adipocytes
  • 相关文献

参考文献22

  • 1Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis[J]. Circulation, 2002, 105(9): 1135-1143.
  • 2Ridker PM. Inflammation, C-reactive protein, and cardiovascular disease: moving past the marker versus mediator debate[J]. Circ Res, 2014, 114(4): 594-595.
  • 3Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ[J]. Mol Cell Endocrinol, 2010, 316(2): 129-139.
  • 4Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism[J]. Trends Endocrinol Metab, 2002, 13(2): 84-89.
  • 5Aprahamian TR, Sam F. Adiponectin in cardiovascular inflammation and obesity[J]. Int J Inflam, 2011, 2011: 376909.
  • 6Waki H, Yamauchi T, Kamon J, et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin[J]. J Biol Chem, 2003, 278(41): 40352-40363.
  • 7Tsao TS, Murrey HE, Hug C, et al. Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30)[J]. J Biol Chem, 2002, 277(33): 29359-29362.
  • 8Wang Y, Lam KS, Yau MH, et al. Post-translational modifications of adiponectin: mechanisms and functional implications[J]. Biochem J, 2008, 409(3): 623-633.
  • 9Wang ZV, Scherer PE. DsbA-L is a versatile player in adiponectin secretion[J]. Proc Natl Acad Sci USA, 2008, 105(47): 18077-18078.
  • 10Liu M, Zhou L, Xu A, et al. A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization[J]. Proc Natl Acad Sci USA, 2008, 105(47): 18302-18307.

二级参考文献37

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3059
  • 2Suganami T,,Nishida J,Ogawa Y.Aparacrine loop between adi-pocytes and macrophages aggravates inflammatory changes:roleof free fatty acids and tumor necrosis factor alpha. Arteriosclerosis Thrombosis and Vascular Biology . 2005
  • 3Dandona P,Aljada A,Bandyopadhyay A.Inflammation: the link between insulin resistance, obesity and diabetes. Trends in Immunology . 2004
  • 4Schenk S,Saberi M,Olefsky JM.Insulin sensitivity:modulation by nutrients and inflammation. The Journal of Clinical Investigation . 2008
  • 5Kadowaki T,Yamauchi T,Kubota N,Hara K,Ueki K.Adi ponectin and adiponectin receptors in obesity-linked insulin resistance. Novartis Foundation Symposium . 2007
  • 6Frayn KN,Fielding BA,Karpe F.Adipose tissue fatty acid metabolism and cardiovascular disease. Current Opinion in Lipidology . 2005
  • 7Feinstein DL,Spagnolo A,Akar C,et al.Receptor-independent actions of PPAR thiazolidinedione agonists:is mitochondrial function the key. Biochemical Pharmacology . 2005
  • 8Kralisch S,Sommer G,Deckert CM, et al.Adipokines in diabetes and cardiovascular diseases. Minerva Endocrinologica . 2007
  • 9Matsubara M,Katayose S,Maruoka S.Decreased plasma adiponectin concentrations in nondiabetic women with elevated homeostasis model assessment ratios. European Journal of Endocrinology . 2003
  • 10Katsiougiannis S,Kapsogeorgou EK,Manoussakis MN,et al.Salivary gland epithelial cells:a new source of theimmunoregulatory hormone adiponectin. Arthritis and Rheumatism . 2006

共引文献13

同被引文献23

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部